Virax Biolabs Group Ltd (VRAX) stock
VRAXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 6, 2026Score 9/30
$0.43−0.02 (-3.39%)
Close on Nov 18, 2026Market cap $249.06KP/E –Yield –
Virax Biolabs price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Virax Biolabs's price to book ratio was 0.0× on Nov 11, 2026, against 0.3× a year earlier. Over the last 4 years it ranged from 0.0× to 2.2×, with a median of 0.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.0× | −0.2 |
| 2025 | Dec 31, 2025 | 0.3× | −0.8 |
| 2024 | Dec 31, 2024 | 1.1× | +0.8 |
| 2023 | Dec 29, 2023 | 0.2× | – |
See a number that looks wrong?